TELA BIO INC. - COMMON STOCK

TELA Bio Announces Changes to its Board of Directors

02 يونيو 2021 06:00:01 بحسب Nasdaq GlobeNewswire

TELA Bio Names Marissa Conrad as Vice President of Clinical and Regulatory Affairs

25 مايو 2021 06:00:01 بحسب Nasdaq GlobeNewswire

TELA Bio to Participate in Upcoming Investor Conferences

21 مايو 2021 06:00:00 بحسب Nasdaq GlobeNewswire

TELA Bio Initiates BRAVO II Study of OviTex® for the Robotic Repair of Ventral Hernias

19 مايو 2021 06:00:00 بحسب Nasdaq GlobeNewswire

TELA Bio Announces First Quarter 2021 Financial Results

13 مايو 2021 15:02:00 بحسب Nasdaq GlobeNewswire

TELA Bio to Announce First Quarter 2021 Financial Results

29 أبريل 2021 15:00:00 بحسب Nasdaq GlobeNewswire

TELA Bio Announces Fourth Quarter and Full Year 2020 Financial Results

24 مارس 2021 15:01:00 بحسب Nasdaq GlobeNewswire

TELA Bio Announces 12-Month Analysis from BRAVO Study of OviTex® for Ventral Hernia Repair

18 مارس 2021 06:00:00 بحسب Nasdaq GlobeNewswire

TELA Bio to Report Fourth Quarter and Full Year 2020 Financial Results on March 24, 2021

02 مارس 2021 06:00:01 بحسب Nasdaq GlobeNewswire

TELA Bio to Participate in Upcoming BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

04 فبراير 2021 06:00:00 بحسب Nasdaq GlobeNewswire

TELA Bio Reports Preliminary Results for Fourth Quarter and Full Year 2020

14 يناير 2021 06:00:00 بحسب Nasdaq GlobeNewswire

TELA Bio to Participate in Upcoming Needham Virtual Growth Conference

06 يناير 2021 06:00:00 بحسب Nasdaq GlobeNewswire

TELA Bio Appoints Renowned Surgeon as Vice President of Clinical Development

05 يناير 2021 06:00:01 بحسب Nasdaq GlobeNewswire